Bone and Soft Tissue Pathology Practice Questions

Q: What is the average time interval between radiation exposure and genesis of post-radiation osteosarcoma?

16 yrs. ***16 yrs*** - The latency period for **radiation-induced osteosarcomas** is typically long, often exceeding a decade. - Studies have shown the average interval between therapeutic radiation and the development of osteosarcoma to be around **10-20 years**, with 16 years being a well-supported average. *4 yrs* - A 4-year interval is generally too short for the development of a **secondary osteosarcoma** after radiation exposure. - While other radiation-induced pathologies might manifest earlier, the transformation to osteosarcoma requires a sustained period of genetic damage and cellular changes. *8 yrs* - An 8-year latency period is still relatively short for most radiation-induced osteosarcomas to develop. - While some cases might occur within this timeframe, the average and modal latency periods are typically longer, reflecting the multi-step process of **carcinogenesis**. *2 yrs* - A 2-year interval is exceptionally rare for the development of a **radiation-induced osteosarcoma**. - This short period does not align with the known biological mechanisms and latency associated with radiation-induced bone malignancies.

Q: Perifascicular atrophy is seen in -

Dermatomyositis. ***Dermatomyositis*** - **Perifascicular atrophy**, characterized by muscle fiber atrophy predominantly at the periphery of muscle fascicles, is a **pathognomonic microscopic feature** of dermatomyositis [1]. - This specific pattern of atrophy is due to microvascular involvement and **ischemia** affecting the perimysial capillaries and their surrounding muscle fibers [1]. *Wilson disease* - Wilson disease is a **genetic disorder** of copper metabolism, primarily affecting the liver and brain, leading to **neurological symptoms** and **hepatic dysfunction** [3]. - While it can cause muscle weakness due to central nervous system involvement, it does not typically present with perifascicular atrophy on muscle biopsy. *Becker's dystrophy* - Becker's muscular dystrophy is an **X-linked recessive disorder** caused by mutations in the **dystrophin gene**, leading to attenuated but not absent dystrophin [2]. - Muscle biopsy typically shows **fiber size variability**, **internalized nuclei**, and occasional degenerating/regenerating fibers, but not perifascicular atrophy [2]. *Polymyositis* - Polymyositis is an **inflammatory myopathy** that primarily affects the proximal muscles, causing symmetrical weakness. - Muscle biopsy in polymyositis typically shows **endomyosial inflammation** with cytotoxic T-cell infiltration and muscle fiber necrosis, but **lacks perifascicular atrophy** [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1240-1242. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1244-1245. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 394-395.

Q: Which of the following is not true about osteosarcoma?

Most commonly arises in the epiphyseal region. ***Most commonly arises in the epiphyseal region*** - This statement is **FALSE** - osteosarcoma most commonly arises in the **metaphyseal region** of long bones, particularly around the knee (distal femur, proximal tibia) and proximal humerus [1]. - The metaphysis is the region where bone growth is most active, which explains why osteosarcoma preferentially occurs there. - The epiphysis (growth plate region) is **not** the typical location for osteosarcoma. *Seen in the metaphyseal region of the long bones* - This is **TRUE** - osteosarcoma characteristically arises in the **metaphyseal regions** of long bones, especially around the knee and proximal humerus where growth is most active [1]. *Lung metastasis is common* - This is **TRUE** - the lungs are the most common site of distant metastasis in osteosarcoma, occurring in up to 80% of patients who develop metastatic disease [1]. - Pulmonary metastasis significantly impacts prognosis and treatment [1]. *Secondary osteosarcoma is seen in older age groups* - This is **TRUE** - while primary osteosarcoma affects children and young adults (peak 10-20 years), **secondary osteosarcoma** occurs in older patients, typically arising in association with Paget's disease, prior radiation therapy, or bone infarcts [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1200-1202.

Q: Rate of newly synthesized osteoid mineralization can be best estimated by -

Tetracycline labeling. ***Tetracycline labeling*** - **Tetracycline** is incorporated into newly forming bone (osteoid) at the mineralization front because of its **calcium-chelating properties**. - By administering two doses of tetracycline at a known interval, the distance between the two fluorescent bands can be measured to calculate the **mineralization apposition rate**, which reflects the rate of new osteoid mineralization. *Calcein stain* - **Calcein** is another fluorescent marker that can be used for bone labeling, similar to tetracycline, but it is less commonly used in clinical practice. - While it labels mineralizing bone, the question asks for the **best** method for estimating the *rate* of mineralization, for which tetracycline's historical and established two-dose method is superior. *Von Kossa stain* - The **Von Kossa stain** highlights mineralized bone by precipitating silver in areas where calcium salts are present, thus indirectly staining the mineral component. - It does not directly assess the *rate* of mineralization or the difference between newly synthesized and pre-existing mineralized bone. *Alizarin red stain* - **Alizarin red S** is a dye that stains calcium deposits a red-orange color, making it useful for identifying areas of mineralization. - Like Von Kossa, it indicates the presence of calcium but does not provide a quantitative measure of the *rate* at which newly formed osteoid is mineralizing over time.

Q: Osteoporosis is characterized most commonly by:

Decreased bone mass and decreased bone density. ***Decreased bone mass and decreased bone density*** - **Osteoporosis** is fundamentally defined by a reduction in the quantity of bone tissue, leading to both **decreased bone mass** (total amount of bone) and **decreased bone density** (how tightly packed the bone tissue is) [1]. - This reduction in bone mass and density results in weakened bones that are prone to **fractures** [2]. *Increased bone density and increased bone mass* - This description represents the opposite of osteoporosis, characterizing **healthy bone** or conditions like **osteopetrosis** (but even in osteopetrosis, bone quality is often poor despite high density). - Conditions with increased bone density and mass are associated with stronger bones, not the fragility seen in osteoporosis. *Increased bone formation and increased bone density* - While increased bone formation can lead to increased bone density, this combination describes a process of **bone growth** or **healing**, not osteoporosis. - In osteoporosis, the balance between bone formation and resorption is tipped towards excessive resorption or inadequate formation [2]. *Increased bone formation only* - Increased bone formation alone, without considering resorption rates, does not fully characterize bone health or osteoporosis. - In osteoporosis, there is often a **net loss of bone** due to resorption outpacing formation or formation being insufficient to maintain bone mass [1], [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 665-666. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1190-1191.

Q: Osteoporosis in menopause typically affects

Trabecular bone. ***Trabecular bone*** - **Trabecular bone**, also known as **spongy bone**, is metabolically more active and has a higher surface-to-volume ratio, making it more susceptible to rapid bone loss due to estrogen deficiency in menopause [1][2]. - Common fracture sites associated with menopausal osteoporosis, such as the **vertebrae** and **distal radius**, are rich in trabecular bone [2]. *Periosteum* - The **periosteum** is a membrane covering the outer surface of bones, primarily involved in bone growth, repair, and nutrient supply, not the primary site of bone loss in osteoporosis. - While it plays a role in bone metabolism, it is not directly targeted by the bone loss mechanism seen in menopausal osteoporosis affecting bone density. *Compact bone* - **Compact bone**, or cortical bone, is denser and forms the outer layer of most bones; it remodels at a slower rate than trabecular bone [1]. - While compact bone is affected in later stages of osteoporosis, the initial and more rapid bone loss in menopause primarily occurs in the more metabolically active trabecular bone [1][2]. *Metaphysis* - The **metaphysis** is the wide portion of a long bone between the epiphysis and the diaphysis, containing both compact and trabecular bone. - While fractures in this region can occur, the term refers to a region of the bone, not a specific type of bone tissue preferentially affected by menopausal osteoporosis more than trabecular bone itself. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 662-663. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1190-1191.

Q: In a patient with gouty arthritis, synovial fluid aspiration will show:

Monosodium Urate crystals. ***Monosodium Urate crystals*** - The definitive diagnosis of **gouty arthritis** is made by identifying **needle-shaped, negatively birefringent monosodium urate crystals** in the synovial fluid [1]. - These crystals are formed from **elevated uric acid levels** and precipitate in joints, triggering acute inflammation [2]. *Calcium Pyrophosphate crystals* - These crystals are characteristic of **pseudogout**, or **calcium pyrophosphate deposition disease (CPPD)**, and are typically **rhomboid-shaped and positively birefringent** [3]. - While both gout and pseudogout cause acute arthritis, the **crystal morphology and birefringence** differentiate them [3]. *Mononuclear Leucocytosis* - **Mononuclear leucocytosis** in synovial fluid is more commonly seen in **chronic inflammatory conditions** or some **viral arthritides**, not typically in acute gout attacks. - Acute gout is characterized by a strong **neutrophilic inflammatory response** [1]. *Polymorphonuclear Leukocytosis* - While **polymorphonuclear leukocytosis** (predominantly neutrophils) is indeed seen in the synovial fluid of patients with acute gout due to the intense inflammatory response, it is a **non-specific finding** of inflammation [1]. - It does not definitively diagnose gout, as it can be present in other inflammatory arthritides, including **septic arthritis**, making the **crystal identification crucial**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1218-1220. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 682-683. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 683-684.

Q: All are true regarding myositis ossificans progressiva except -

Progressive form of normal myositis. ***Progressive form of normal myositis*** - **Myositis ossificans progressiva (fibrodysplasia ossificans progressiva)** is a rare genetic disorder, not a progressive form of typical myositis (muscle inflammation) [1]. - It involves the progressive **heterotopic ossification** of **connective tissues**, ligaments, and tendons, forming bone in abnormal locations, distinct from an exaggerated inflammatory response [1]. *Respiratory problems* - Patients frequently develop **restrictive lung disease** due to ossification of the intercostal muscles and diaphragm, as well as ankylosis of the spine and ribs. - This severely limits chest wall movement, leading to **respiratory insufficiency** and being a major cause of morbidity and mortality. *Usually involves children* - The onset of **fibrodysplasia ossificans progressiva (FOP)** typically occurs in **early childhood**, often manifesting with congenital malformations of the great toes. - Episodes of heterotopic ossification usually begin within the first two decades of life, affecting soft tissues and progressively leading to joint ankylosis. *Ankylosis* - **Ankylosis** is a hallmark feature due to the extensive formation of **heterotopic bone** across joints, tethering them in fixed positions. - This leads to severe and progressive loss of mobility, significantly impairing daily activities and quality of life. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 691-692.

Q: Which of the following is NOT a TRUE statement about fibrous dysplasia?

The polyostotic form is common in adults. ***The polyostotic form is common in adults*** - This statement is **not true**. The **polyostotic form** of fibrous dysplasia is more commonly diagnosed in **childhood** due to its widespread nature and earlier symptomatic presentation [1]. - While it can persist into adulthood, its onset and peak diagnosis are typically during formative years, making it less "common in adults" as an inaugural presentation [1]. *Thin cortices* - This is a **true statement** regarding fibrous dysplasia. The abnormal fibrous tissue expansion often leads to **thinning of the cortical bone**. - The expanded intramedullary lesion places pressure on the surrounding cortex, causing it to become attenuated but rarely broken. *Characterised by replacement of normal lamellar bone by an abnormal fibrous tissue* - This is a **true statement** and describes the fundamental pathology of fibrous dysplasia [1]. Normal **lamellar bone** is replaced by an immature, woven bone embedded within a **fibrous stroma**. - This disordered bone formation is due to a **post-zygotic mutation in the GNAS1 gene**, leading to abnormal osteoblast differentiation [1]. *Ground-glass appearance* - This is a **true statement** and a characteristic radiographic feature of fibrous dysplasia. The disorganized **woven bone** and fibrous matrix within the lesion absorb X-rays in a diffuse, homogeneous manner. - This results in a **classic "ground-glass" or "smoked glass" appearance** on plain radiographs, distinguishing it from other bone lesions. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, p. 1208.

Q: MIC-2 (CD99) expression is most characteristically associated with

Ewings sarcoma. ***Ewings sarcoma*** - **MIC-2 (CD99)** is a highly sensitive and widely used immunohistochemical marker for **Ewing sarcoma** [2]. - Its expression is observed in nearly **95%** of Ewing sarcoma cases, reflecting the characteristic neuroectodermal differentiation of this tumor. *Alveolar soft tissue sarcoma* - This tumor typically expresses **TFE3**, a transcription factor involved in its unique genomic translocation, and is generally **negative for CD99**. - It is characterized by a distinctive **alveolar growth pattern** and granular eosinophilic cytoplasm, differentiating it from Ewing sarcoma. *Osteosarcoma* - Osteosarcomas are primarily characterized by the production of **osteoid** by malignant cells and are typically **negative for CD99** [1]. - Immunohistochemical markers for osteosarcoma often include **alkaline phosphatase** and osteocalcin. *Dermatofibrosarcoma protuberans* - This tumor is characterized by expression of **CD34** and a specific **COL1A1-PDGFB fusion gene**. - It is typically **negative for CD99**, which helps differentiate it from other spindle cell tumors. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 673-674. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 671-672.

Question 1

What is the average time interval between radiation exposure and genesis of post-radiation osteosarcoma?

Accepted Answer

16 yrs

Answer

4 yrs

Answer

8 yrs

Answer

2 yrs

Question 2

Perifascicular atrophy is seen in -

Accepted Answer

Dermatomyositis

Answer

Wilson disease

Answer

Becker's dystrophy

Answer

Polymyositis

Question 3

Which of the following is not true about osteosarcoma?

Accepted Answer

Most commonly arises in the epiphyseal region

Answer

Seen in the metaphyseal region of the long bones

Answer

Lung metastasis is common

Answer

Secondary osteosarcoma is seen in older age groups

Question 4

Rate of newly synthesized osteoid mineralization can be best estimated by -

Accepted Answer

Tetracycline labeling

Answer

Calcein stain

Answer

Von Kossa stain

Answer

Alizarin red stain

Question 5

Osteoporosis is characterized most commonly by:

Accepted Answer

Decreased bone mass and decreased bone density

Answer

Increased bone density and increased bone mass

Answer

Increased bone formation and increased bone density

Answer

Increased bone formation only

Question 6

Osteoporosis in menopause typically affects

Accepted Answer

Trabecular bone

Answer

Periosteum

Answer

Compact bone

Answer

Metaphysis

Question 7

In a patient with gouty arthritis, synovial fluid aspiration will show:

Accepted Answer

Monosodium Urate crystals

Answer

Calcium Pyrophosphate crystals

Answer

Mononuclear Leucocytosis

Answer

Polymorphonuclear Leukocytosis

Question 8

All are true regarding myositis ossificans progressiva except -

Accepted Answer

Progressive form of normal myositis

Answer

Respiratory problems

Answer

Usually involves children

Answer

Ankylosis

Question 9

Which of the following is NOT a TRUE statement about fibrous dysplasia?

Accepted Answer

The polyostotic form is common in adults

Answer

Thin cortices

Answer

Characterised by replacement of normal lamellar bone by an abnormal fibrous tissue

Answer

Ground-glass appearance

Question 10

MIC-2 (CD99) expression is most characteristically associated with

Accepted Answer

Ewings sarcoma

Answer

Alveolar soft tissue sarcoma

Answer

Osteosarcoma

Answer

Dermatofibrosarcoma protuberans

Bone and Soft Tissue Pathology — MCQs

Bone and Soft Tissue Pathology — MCQs

On this page

Practice by Chapter

Want unlimited practice?